Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease

Published:2021-04-23 Issue:5 Volume:35 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Caputo Mara¹,Kurhe Yeshwant¹,Kumari Sima¹,Cansby Emmelie¹,Amrutkar Manoj²,Scandalis Eli³,Booten Sheri L.³,Ståhlman Marcus⁴,Borén Jan⁴,Marschall Hanns‐Ulrich⁴,Aghajan Mariam³,Mahlapuu Margit¹

Affiliation:

1. Department of Chemistry and Molecular Biology University of Gothenburg and Sahlgrenska University Hospital Gothenburg Sweden

2. Department of Hepato‐Pancreato‐Biliary Surgery Institute of Clinical Medicine University of Oslo Oslo Norway

3. Ionis Pharmaceuticals Carlsbad CA USA

4. Wallenberg Laboratory Department of Molecular and Clinical Medicine Institute of Medicine University of Gothenburg and Sahlgrenska University Hospital Gothenburg Sweden

Funder

Vetenskapsrådet

European Foundation for the Study of Diabetes

Novo Nordisk Fonden

Hjärt-Lungfonden

Kungl. Vetenskaps- och Vitterhets-Samhället i Göteborg

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202002671RR